A Registry of Chinese AL Amyloidosis Patients Treated With Subcutaneous or Intravenous Daratumumab
Clinical trial NCT05277493 · UNKNOWN
Trial details
- NCT number
- NCT05277493
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-30
- Primary completion
- 2025-03-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.